XML 18 R2.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Balance Sheets
¥ in Millions
Dec. 31, 2023
USD ($)
Dec. 31, 2022
USD ($)
Current Assets    
Cash, cash equivalents, and restricted cash $ 503,505 $ 1,433,158
Accounts receivable, net of allowance for CECL - trade receivable of $47,199 and $231,937, respectively 164,170 967,819
Prepaid expenses 11,765 26,721
Other receivables 3,069 64,023
Total Current Assets 682,509 2,491,721
Property and equipment, net 3,307,371 3,129,884
Other Assets    
Deferred tax assets   11,121
VAT credit 9,362 2,349
Total Other Assets 9,362 13,470
Total Assets 3,999,242 5,635,075
Current Liabilities:    
Accounts payable and accrued liabilities 101,969 313,086
Deferred income 20,068 20,179
Short-term loans payable   372,679
Total Current Liabilities 122,037 705,944
Total Liabilities 122,037 705,944
Equity:    
Ordinary shares: 50,000,000 shares authorized, par value: $0.001 per share, 11,675,216 shares issued and outstanding as of December 31, 2023 and 2022 11,675 11,675
Additional paid in capital 6,845,394 6,845,394
Statutory reserve 327,140 327,140
Retained earnings (3,363,436) (2,202,990)
Accumulated other comprehensive (loss) income 56,432 (52,088)
Total Shareholders' Equity 3,877,205 4,929,131
Total Liabilities and Equity $ 3,999,242 $ 5,635,075